Difference between revisions of "Rizzo Lab Members and Contact Information"
From Rizzo_Lab
Line 86: | Line 86: | ||
|- | |- | ||
|Rodger Tan | |Rodger Tan | ||
− | ||Undergraduate | + | ||Undergraduate |
||Test Set, benchmarking, de novo design | ||Test Set, benchmarking, de novo design | ||
||2019 - 2020 | ||2019 - 2020 | ||
Line 92: | Line 92: | ||
|- | |- | ||
|Scott Laverty | |Scott Laverty | ||
− | ||Undergraduate | + | ||Undergraduate |
||DOCK6 benchmarking with Autodock4 | ||DOCK6 benchmarking with Autodock4 | ||
||2019 - 2020 | ||2019 - 2020 | ||
Line 98: | Line 98: | ||
|- | |- | ||
|Stephen Telehany | |Stephen Telehany | ||
− | ||Masters | + | ||Masters |
||Zika Virus | ||Zika Virus | ||
||2017 - 2020 | ||2017 - 2020 | ||
Line 104: | Line 104: | ||
|- | |- | ||
|Yuchen Zhou | |Yuchen Zhou | ||
− | || | + | ||PhD / Masters |
||BoNT/E, DOCK scoring functions, FABP5 | ||BoNT/E, DOCK scoring functions, FABP5 | ||
||2012 - 2018 | ||2012 - 2018 | ||
Line 110: | Line 110: | ||
|- | |- | ||
|Jiaye Guo | |Jiaye Guo | ||
− | || | + | ||PhD |
||Solvated footprints, Small-molecule inhibitor for HER2 | ||Solvated footprints, Small-molecule inhibitor for HER2 | ||
||2013 - 2018 | ||2013 - 2018 | ||
Line 116: | Line 116: | ||
|- | |- | ||
|Courtney Singleton | |Courtney Singleton | ||
− | ||MD / PhD | + | ||MD/PhD |
||HIVgp41, De novo design, genetic algorithm | ||HIVgp41, De novo design, genetic algorithm | ||
||2014 - 2018 | ||2014 - 2018 | ||
Line 122: | Line 122: | ||
|- | |- | ||
|Dwight McGee | |Dwight McGee | ||
− | || | + | ||Postdoc |
||HIVgp41, Free energy calculations, de novo design | ||HIVgp41, Free energy calculations, de novo design | ||
||2015 - 2018 | ||2015 - 2018 | ||
Line 128: | Line 128: | ||
|- | |- | ||
|Brian Fochtman | |Brian Fochtman | ||
− | || | + | ||PhD |
||HIVgp41, DOCK development | ||HIVgp41, DOCK development | ||
||2011 - 2017 | ||2011 - 2017 | ||
Line 134: | Line 134: | ||
|- | |- | ||
|Lingling Jiang | |Lingling Jiang | ||
− | || | + | ||PhD |
||HIVgp41, Pharmacophore modeling | ||HIVgp41, Pharmacophore modeling | ||
||2010 - 2015 | ||2010 - 2015 | ||
Line 140: | Line 140: | ||
|- | |- | ||
|Brian Ralph | |Brian Ralph | ||
− | ||Undergraduate | + | ||Undergraduate |
||Fatty acid binding protein, De novo design | ||Fatty acid binding protein, De novo design | ||
||2013 - 2015 | ||2013 - 2015 | ||
Line 146: | Line 146: | ||
|- | |- | ||
|William J. Allen | |William J. Allen | ||
− | || | + | ||Postdoc |
||HIVgp41, DOCK development | ||HIVgp41, DOCK development | ||
||2011 - 2015 | ||2011 - 2015 | ||
Line 152: | Line 152: | ||
|- | |- | ||
|Yulin Huang | |Yulin Huang | ||
− | || | + | ||PhD |
||EGFR, IGF-IR | ||EGFR, IGF-IR | ||
||2008 - 2013 | ||2008 - 2013 | ||
Line 158: | Line 158: | ||
|- | |- | ||
|Sudipto Mukherjee | |Sudipto Mukherjee | ||
− | || | + | ||PhD / Masters |
||DOCK development, HIVgp41 | ||DOCK development, HIVgp41 | ||
||2005 - 2012 | ||2005 - 2012 | ||
Line 164: | Line 164: | ||
|- | |- | ||
|[http://docking.org/~tbalius/ Trent E. Balius] | |[http://docking.org/~tbalius/ Trent E. Balius] | ||
− | || | + | ||PhD |
||EGFR, HIVgp41, DOCK development | ||EGFR, HIVgp41, DOCK development | ||
||2007 - 2012 | ||2007 - 2012 | ||
Line 170: | Line 170: | ||
|- | |- | ||
|Patrick Holden | |Patrick Holden | ||
− | || | + | ||Masters |
||HIVgp41 | ||HIVgp41 | ||
||2009 - 2011 | ||2009 - 2011 | ||
Line 176: | Line 176: | ||
|- | |- | ||
| Jibril Ashiru-Balogun | | Jibril Ashiru-Balogun | ||
− | ||Undergraduate | + | ||Undergraduate |
||HIVgp41 | ||HIVgp41 | ||
||2010 - 2011 | ||2010 - 2011 | ||
Line 182: | Line 182: | ||
|- | |- | ||
| Brian Shea | | Brian Shea | ||
− | ||Undergraduate | + | ||Undergraduate |
||Kinases | ||Kinases | ||
||2010 | ||2010 | ||
Line 188: | Line 188: | ||
|- | |- | ||
| Patrick Murphy | | Patrick Murphy | ||
− | ||Undergraduate | + | ||Undergraduate |
||Influenza | ||Influenza | ||
||2009 - 2010 | ||2009 - 2010 | ||
Line 194: | Line 194: | ||
|- | |- | ||
| Rashi Goyal | | Rashi Goyal | ||
− | ||Masters | + | ||Masters |
||Influenza, HIV | ||Influenza, HIV | ||
||2007 - 2010 | ||2007 - 2010 | ||
Line 200: | Line 200: | ||
|- | |- | ||
| Brian McGillick | | Brian McGillick | ||
− | ||Masters | + | ||Masters |
||HIVgp41 | ||HIVgp41 | ||
||2007 - 2010 | ||2007 - 2010 | ||
Line 206: | Line 206: | ||
|- | |- | ||
| Kenneth Ascher | | Kenneth Ascher | ||
− | ||Undergraduate | + | ||Undergraduate |
||DOCK method development | ||DOCK method development | ||
||2009 - 2010 | ||2009 - 2010 | ||
Line 212: | Line 212: | ||
|- | |- | ||
| Dimir Abrar | | Dimir Abrar | ||
− | ||Undergraduate | + | ||Undergraduate |
||HIVRT crossdocking | ||HIVRT crossdocking | ||
||2008 - 2009 | ||2008 - 2009 | ||
Line 218: | Line 218: | ||
|- | |- | ||
| Chetan Raj Rupakheti | | Chetan Raj Rupakheti | ||
− | ||Summer | + | ||Summer |
||HIVgp41 | ||HIVgp41 | ||
||2008 | ||2008 | ||
Line 230: | Line 230: | ||
|- | |- | ||
| Noel Carrascal | | Noel Carrascal | ||
− | || | + | ||PhD (co-advisor) |
||DOCK method development | ||DOCK method development | ||
||2005 - 2007 | ||2005 - 2007 | ||
Line 236: | Line 236: | ||
|- | |- | ||
| Ricky Chachra | | Ricky Chachra | ||
− | ||Undergraduate | + | ||Undergraduate |
||Influenza drug resistance | ||Influenza drug resistance | ||
||2005 - 2007 | ||2005 - 2007 | ||
Line 242: | Line 242: | ||
|- | |- | ||
| Amee Patel | | Amee Patel | ||
− | ||Undergraduate | + | ||Undergraduate |
||Testset development | ||Testset development | ||
||2005 - 2007 | ||2005 - 2007 |
Revision as of 14:58, 5 November 2020
CONTACT
Robert C. Rizzo
Stony Brook University Department of Applied Mathematics and Statistics Office: Math Tower 1-111 Lab: Math Tower 3-129 Stony Brook, NY 11794-3600 |
Email: rizzorc [at] gmail [dot] com
Office: (631) 632-9340 Lab: (631) 632-8519 Fax: (631) 632-8490 Website: rizzolab.org Wiki: ringo.ams.sunysb.edu |
---|
CURRENT MEMBERS
Name | Status | Project | Year | |
---|---|---|---|---|
Dr. Robert C. Rizzo | rizzorc [at] gmail [dot] com | Principal investigator | Group leader | 2004 - present |
Guilherme Duarte Ramos Matos | Guilherme.duarteramosmatos [at] stonybrook [dot] edu | Postdoctoral Researcher | Cheminformatics integration, COVID-19 | 2019 - present |
Lauren Prentis | lauren.prentis [at] stonybrook [dot] edu | Doctoral Student | Tsg101, de novo design, covalent docking, genetic algorithm | 2016 - present |
John Bickel | john.bickel [at] stonybrook [dot] edu | Doctoral Student | de novo design, COVID-19 | 2019 - present |
Christopher Corbo | christopher.corbo [at] stonybrook [dot] edu | Doctoral Student | Test Set benchmarking, COVID-19 | 2019 - present |
Steven Pak | steven.pak [at] stonybrook [dot] edu | Doctoral Student | de novo design, FGFR2, Cheminformatics | 2020 - present |
FORMER MEMBERS
Name | Status | Project | Year | New Position |
---|---|---|---|---|
Rodger Tan | Undergraduate | Test Set, benchmarking, de novo design | 2019 - 2020 | -- |
Scott Laverty | Undergraduate | DOCK6 benchmarking with Autodock4 | 2019 - 2020 | UPenn Chemistry Doctoral Program |
Stephen Telehany | Masters | Zika Virus | 2017 - 2020 | -- |
Yuchen Zhou | PhD / Masters | BoNT/E, DOCK scoring functions, FABP5 | 2012 - 2018 | Postdoc, Filizola Lab at ISMMS |
Jiaye Guo | PhD | Solvated footprints, Small-molecule inhibitor for HER2 | 2013 - 2018 | Postdoc, Chodera Lab at MSKCC |
Courtney Singleton | MD/PhD | HIVgp41, De novo design, genetic algorithm | 2014 - 2018 | Stony Brook Medical School |
Dwight McGee | Postdoc | HIVgp41, Free energy calculations, de novo design | 2015 - 2018 | Silicon Therapeutics |
Brian Fochtman | PhD | HIVgp41, DOCK development | 2011 - 2017 | The FDA |
Lingling Jiang | PhD | HIVgp41, Pharmacophore modeling | 2010 - 2015 | Novo Nordisk |
Brian Ralph | Undergraduate | Fatty acid binding protein, De novo design | 2013 - 2015 | Dental school |
William J. Allen | Postdoc | HIVgp41, DOCK development | 2011 - 2015 | TACC |
Yulin Huang | PhD | EGFR, IGF-IR | 2008 - 2013 | Wall Street |
Sudipto Mukherjee | PhD / Masters | DOCK development, HIVgp41 | 2005 - 2012 | Postdoc, Voelz Lab |
Trent E. Balius | PhD | EGFR, HIVgp41, DOCK development | 2007 - 2012 | Project Lead, RAS Computational Chemistry Team in the Cancer Research Tecnhology Program (CRTP) at the Frederick National Lab for Cancer Research |
Patrick Holden | Masters | HIVgp41 | 2009 - 2011 | -- |
Jibril Ashiru-Balogun | Undergraduate | HIVgp41 | 2010 - 2011 | -- |
Brian Shea | Undergraduate | Kinases | 2010 | -- |
Patrick Murphy | Undergraduate | Influenza | 2009 - 2010 | -- |
Rashi Goyal | Masters | Influenza, HIV | 2007 - 2010 | -- |
Brian McGillick | Masters | HIVgp41 | 2007 - 2010 | -- |
Kenneth Ascher | Undergraduate | DOCK method development | 2009 - 2010 | -- |
Dimir Abrar | Undergraduate | HIVRT crossdocking | 2008 - 2009 | -- |
Chetan Raj Rupakheti | Summer | HIVgp41 | 2008 | -- |
Bentley Strockbine | Postdoc | HIVgp41 | 2005 - 2007 | -- |
Noel Carrascal | PhD (co-advisor) | DOCK method development | 2005 - 2007 | -- |
Ricky Chachra | Undergraduate | Influenza drug resistance | 2005 - 2007 | -- |
Amee Patel | Undergraduate | Testset development | 2005 - 2007 | -- |